Search Results 511-520 of 14739 for anti-TNF drugs

  1. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Genvoya. Descriptions. Elvitegravir, cobicistat ...

  2. Antiviral Drugs and COVID-19 - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

    Dr. Caulfield's Drug Discovery, Design and Optimization for Novel Therapeutics Lab at Mayo Clinic studies how to prevent viruses from binding, entering and ...

  3. Chlorpheniramine, Ibuprofen, And Phenylephrine (Oral Route) Description and Brand Names - Mayo Clinic

    Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used in this combination to relieve inflammation, swelling, and pain. This medicine is ...

  4. Mayo Clinic launches Cardiac Sarcoidosis Clinic

    Drugs & Supplements · Healthy ... TNF-inhibition with either infliximab or adalimumab should be considered. ... anti-arrhythmic therapy. VT recurrences are ...

  5. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Known anti-human anti-chimeric antibody formation; Treatment with infliximab, adalimumab, or etanercept within the past 12 months. Currently taking ...

  6. Testosterone (Transdermal Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Kanamycin (Injection Route) Before Using - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  8. Milnacipran (Oral Route) Description and Brand Names - Mayo Clinic

    It belongs to a group of medicines known as selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). These medicines work by increasing the activity ...

  9. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

  10. 'A living drug' to fight leukemia - Mayo Clinic News Network

    A leukemia treatment that uses a patient's own cells to boost immunity and fight cancer has been forwarded for approval by a U.S. Food and Drug ...